Cravath Publishes Winter 2026 Issue of Alumni Journal
Cravath is one of the preeminent law firms for mergers and acquisitions. Our lawyers are renowned for their outstanding capabilities in complex U.S. and cross‑border deals. Over the past decade, Cravath has represented clients in more than 800 M&A transactions with an aggregate value of over $4 trillion, reflecting the high‑value, high‑impact transactions that we are regularly called upon to execute.
Cravath advises companies in their most critical needs across the full spectrum of corporate transactions, including mergers, acquisitions, divestitures, spin‑offs and joint ventures. In addition to—and often alongside—the mergers and acquisitions that we handle, Cravath is a leading advisor for companies and boards in high‑stakes corporate situations, including hostile takeovers and shareholder activism defense.
Both U.S. and non-U.S. clients rely on our leadership and expertise in their most transformative corporate matters, many of which involve multiple jurisdictions across diverse industries. Our lawyers navigate novel legal and business issues in the areas of consumer products, energy, fintech, healthcare, media and entertainment, pharmaceuticals, retail, technology and telecommunications.
Cravath has been consistently ranked a top‑tier firm for M&A by numerous third‑party publications and is an 11‑time recipient of Law360’s M&A Practice Group of the Year award. Our lawyers regularly earn plaudits from their clients and peers in the market:
Cravath advises companies in their most critical needs across the full spectrum of corporate transactions, including mergers, acquisitions, divestitures, spin‑offs and joint ventures. In addition to—and often alongside—the mergers and acquisitions that we handle, Cravath is a leading advisor for companies and boards in high‑stakes corporate situations, including hostile takeovers and shareholder activism defense.
Both U.S. and non-U.S. clients rely on our leadership and expertise in their most transformative corporate matters, many of which involve multiple jurisdictions across diverse industries. Our lawyers navigate novel legal and business issues in the areas of consumer products, energy, fintech, healthcare, media and entertainment, pharmaceuticals, retail, technology and telecommunications.
Cravath has been consistently ranked a top‑tier firm for M&A by numerous third‑party publications and is an 11‑time recipient of Law360’s M&A Practice Group of the Year award. Our lawyers regularly earn plaudits from their clients and peers in the market:
Deals & Cases
May 01, 2026
On April 27, 2026, Integris, a national leader in managed AI and IT services backed by OMERS Private Equity, announced its intent, subject to regulatory approval, to acquire First Focus, the largest managed service provider serving small and midsize businesses in Australia, New Zealand and the Philippines. Cravath is representing Integris as U.S. counsel in connection with the transaction.
Deals & Cases
April 27, 2026
On April 27, 2026, Thermo Fisher Scientific Inc. (“Thermo Fisher”), the world leader in serving science, announced that it has signed a definitive agreement to sell its microbiology business, which provides antimicrobial susceptibility testing and culture media solutions for clinical, pharmaceutical and food safety testing, to Astorg, a leading pan‑European private equity firm, for consideration of approximately $1.075 billion, consisting of cash and a $50 million seller note. Cravath is representing Thermo Fisher in connection with the transaction.
Deals & Cases
March 31, 2026
On March 31, 2026, Biogen Inc. and Apellis Pharmaceuticals, Inc. announced that the companies have entered into a definitive agreement under which Biogen has agreed to acquire all outstanding shares of Apellis for $41.00 per share in cash at closing, or approximately $5.6 billion. Apellis stockholders will also receive a nontransferable CVR for each Apellis share held, entitling the holder to receive two payments of $2 per share each, contingent on certain annual global net sales thresholds being met for SYFOVRE®. Cravath is representing Biogen in connection with the transaction.
Deals & Cases
March 11, 2026
On March 10, 2026, Elsevier, a global leader in advanced information and decision support and part of RELX, announced it has entered into a definitive agreement to acquire Mytonomy, a leader in video-based patient engagement solutions that will complement Elsevier’s Clinical Solutions portfolio. Cravath is representing RELX in connection with the transaction.
Deals & Cases
March 09, 2026
On March 9, 2026, Universal Health Services, Inc. (“UHS”) announced that it has entered into a definitive agreement to acquire Talkspace, Inc. (“Talkspace”) for $5.25 per share. The enterprise value for the transaction is approximately $835 million. Cravath is representing Talkspace in connection with the transaction.
Activities
April 13, 2026
Cravath partner Faiza J. Saeed was named to The Hollywood Reporter’s annual “Power Lawyers” list, which recognizes attorneys at the “top of their field” who “help keep the wheels of the industry turning” and was published in the April 8, 2026 issue of The Hollywood Reporter Magazine. The feature highlighted Faiza’s representation of Paramount Skydance in its pending $110 billion acquisition of Warner Bros. Discovery, Inc. and the Paramount Special Committee in connection with the company’s $8.4 billion merger with Skydance. She was also recognized for her representation of Hailey Bieber in rhode’s $1 billion acquisition by e.l.f. beauty. This is Faiza’s ninth year being recognized as a “Power Lawyer.”
Publications
April 10, 2026
Cravath partner Daniel J. Cerqueira served as contributing editor of Legal 500’s 2026 “Mergers & Acquisitions Country Comparative Guide,” which was published in April 2026. The guide provides a pragmatic overview of M&A laws and regulations across a variety of jurisdictions. Together with Dan, partner Jin‑Kyu Baek authored the United States chapter of the guide, which reviews M&A trends, the current state of the market, and key considerations for companies and shareholders.
Activities
April 10, 2026
On April 9, 2026, Cravath partner G.J. Ligelis Jr. participated in the International Bar Association’s Asia Pacific Mergers & Acquisitions Conference, which was held April 9‑10, 2026 in Tokyo, Japan. G.J. spoke during a session entitled “The Art of the Deal – Navigating through the Negotiation of Common M&A Issues,” which explored the negotiation positions, perspectives and alternatives of M&A counsel across several jurisdictions, highlighting key strategies and pitfalls to avoid when developing the best available deal.
Activities
April 06, 2026
Four Cravath attorneys were selected to serve on Law360’s 2026 Editorial Advisory Boards: partners Ryan J. Patrone (Capital Markets), Claudia J. Ricciardi (Mergers & Acquisitions) and Jihyun Chung (Private Equity) and of counsel Scott B. Reents (Legal Tech). As Editorial Advisory Board members, they will provide feedback on Law360’s coverage and expert insight on how best to shape future coverage.
Activities
April 01, 2026
Cravath partners Jin‑Kyu Baek, Nicholas A. Dorsey and Lauren Roberta Kennedy were featured in the 2026 edition of “Practice Perspectives: Vault’s Guide to Legal Practice Areas,” which highlights the experiences of practicing lawyers in more than 20 different areas of the law and is published annually.
Deals & Cases
May 01, 2026
On April 27, 2026, Integris, a national leader in managed AI and IT services backed by OMERS Private Equity, announced its intent, subject to regulatory approval, to acquire First Focus, the largest managed service provider serving small and midsize businesses in Australia, New Zealand and the Philippines. Cravath is representing Integris as U.S. counsel in connection with the transaction.
Deals & Cases
April 27, 2026
On April 27, 2026, Thermo Fisher Scientific Inc. (“Thermo Fisher”), the world leader in serving science, announced that it has signed a definitive agreement to sell its microbiology business, which provides antimicrobial susceptibility testing and culture media solutions for clinical, pharmaceutical and food safety testing, to Astorg, a leading pan‑European private equity firm, for consideration of approximately $1.075 billion, consisting of cash and a $50 million seller note. Cravath is representing Thermo Fisher in connection with the transaction.
Deals & Cases
March 31, 2026
On March 31, 2026, Biogen Inc. and Apellis Pharmaceuticals, Inc. announced that the companies have entered into a definitive agreement under which Biogen has agreed to acquire all outstanding shares of Apellis for $41.00 per share in cash at closing, or approximately $5.6 billion. Apellis stockholders will also receive a nontransferable CVR for each Apellis share held, entitling the holder to receive two payments of $2 per share each, contingent on certain annual global net sales thresholds being met for SYFOVRE®. Cravath is representing Biogen in connection with the transaction.
Deals & Cases
March 11, 2026
On March 10, 2026, Elsevier, a global leader in advanced information and decision support and part of RELX, announced it has entered into a definitive agreement to acquire Mytonomy, a leader in video-based patient engagement solutions that will complement Elsevier’s Clinical Solutions portfolio. Cravath is representing RELX in connection with the transaction.
Deals & Cases
March 09, 2026
On March 9, 2026, Universal Health Services, Inc. (“UHS”) announced that it has entered into a definitive agreement to acquire Talkspace, Inc. (“Talkspace”) for $5.25 per share. The enterprise value for the transaction is approximately $835 million. Cravath is representing Talkspace in connection with the transaction.
Activities
April 13, 2026
Cravath partner Faiza J. Saeed was named to The Hollywood Reporter’s annual “Power Lawyers” list, which recognizes attorneys at the “top of their field” who “help keep the wheels of the industry turning” and was published in the April 8, 2026 issue of The Hollywood Reporter Magazine. The feature highlighted Faiza’s representation of Paramount Skydance in its pending $110 billion acquisition of Warner Bros. Discovery, Inc. and the Paramount Special Committee in connection with the company’s $8.4 billion merger with Skydance. She was also recognized for her representation of Hailey Bieber in rhode’s $1 billion acquisition by e.l.f. beauty. This is Faiza’s ninth year being recognized as a “Power Lawyer.”
Publications
April 10, 2026
Cravath partner Daniel J. Cerqueira served as contributing editor of Legal 500’s 2026 “Mergers & Acquisitions Country Comparative Guide,” which was published in April 2026. The guide provides a pragmatic overview of M&A laws and regulations across a variety of jurisdictions. Together with Dan, partner Jin‑Kyu Baek authored the United States chapter of the guide, which reviews M&A trends, the current state of the market, and key considerations for companies and shareholders.
Activities
April 10, 2026
On April 9, 2026, Cravath partner G.J. Ligelis Jr. participated in the International Bar Association’s Asia Pacific Mergers & Acquisitions Conference, which was held April 9‑10, 2026 in Tokyo, Japan. G.J. spoke during a session entitled “The Art of the Deal – Navigating through the Negotiation of Common M&A Issues,” which explored the negotiation positions, perspectives and alternatives of M&A counsel across several jurisdictions, highlighting key strategies and pitfalls to avoid when developing the best available deal.
Activities
April 06, 2026
Four Cravath attorneys were selected to serve on Law360’s 2026 Editorial Advisory Boards: partners Ryan J. Patrone (Capital Markets), Claudia J. Ricciardi (Mergers & Acquisitions) and Jihyun Chung (Private Equity) and of counsel Scott B. Reents (Legal Tech). As Editorial Advisory Board members, they will provide feedback on Law360’s coverage and expert insight on how best to shape future coverage.
Activities
April 01, 2026
Cravath partners Jin‑Kyu Baek, Nicholas A. Dorsey and Lauren Roberta Kennedy were featured in the 2026 edition of “Practice Perspectives: Vault’s Guide to Legal Practice Areas,” which highlights the experiences of practicing lawyers in more than 20 different areas of the law and is published annually.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2026 Cravath, Swaine & Moore LLP.